PERSPECTA

News from every angle

← Back to headlines

Eli Lilly Announces Positive Phase 3 Results for Obesity Drug Retatrutide

Eli Lilly (LLY) has reported positive Phase 3 clinical trial results for its investigational obesity treatment, Retatrutide, marking a significant development in the pharmaceutical company's pipeline.

23 May, 12:01 — 23 May, 12:01
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual5d ago

Eli Lilly (LLY) Announces Positive Phase 3 Results for Obesity Treatment Retatrutide

Read full article →

Related Stories

Extreme Training: What Heat Training Does to the Body

just now

How to effectively protect yourself from mosquitoes to reduce the risk of West Nile virus infection

15m ago

Study Reveals Mosquitoes Can Learn to Ignore Repellents

18m ago

Tips for Staying Cool During Heatwaves Without AC

23m ago